Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors

By Famiglini Valeria   Coluccia Antonio   Brancale Andrea   Pelliccia Sveva   La Regina Giuseppe   Silvestri Romano  

Future Medicinal Chemistry, Vol. 5, Iss. 18, 2013-12 ,pp. : 2141-2156

Future Science

Access to resources Recommend Favorite

Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

By Thomas Michael   Maga Giovanni   Mouscadet Jean-François   Howarth Nicola  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1063-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase

By D'cruz Osmond J.   Uckun Fatih M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 329-350

Informa Healthcare

Access to resources Recommend Favorite

Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in rabbit, mouse and human: identification of fluorine NIH shift metabolites using NMR and tandem MS

By Dear G. J.   Ismail I. M.   Mutch P. J.   Plumb R. S.   Davies L. H.   Sweatman B. C.  

Xenobiotica, Vol. 30, Iss. 4, 2000-04 ,pp. : 407-426

Informa Healthcare

Access to resources Recommend Favorite

Structural Mechanisms of Drug Resistance for Mutations at Codons 181 and 188 in HIV-1 Reverse Transcriptase and the Improved Resilience of Second Generation Non-nucleoside Inhibitors

By Ren J.   Nichols C.   Bird L.   Chamberlain P.   Weaver K.   Short S.   Stuart D.I.   Stammers D.K.  

Journal of Molecular Biology, Vol. 312, Iss. 4, 2001-09 ,pp. : 795-805

Academic Press

Access to resources Recommend Favorite